Archives for September 15, 2008

← 2008

Manufacturing facilities: News in brief

By Nick Taylor

in-PharmaTechnologist.com's latest round-up of developments in pharmaceutical manufacturing features news of the world’s “biggest pharmaceutical allergen production unit”, Lentigen’s relocation and a cytotoxic robot.

Artelis and Selexis’ project achieves record MAb yield

By Gareth Macdonald

Artelis president Jose Castilo believes that the record MAb yield from CHO cells grown in its iCELLis bioreactor shows the platform could shift the paradigm for the "production of recombinant proteins.”

Millipore plans to close four facilities

By Nick Taylor

Millipore is planning on closing four facilities, generating annual savings of up to $15m, as it attempts to cut costs by streamlining its operations.

India tipped for 15% share of clinical sector by 2011

By Phil Taylor

Shifting clinical trial operations from Western markets to India can reap substantial benefits for sponsors in saved costs and time, according to KPMG’s just-published report India Pharma Inc.

Outsourcing drives growth in trial sector, Bilcare GCS

By Gareth Macdonald

Bilcare GCS, the clinical supplies arm of Indian packaging giant Bilcare, has considerably expanded its Phase III trial offering in an effort to provide drugmakers with a complete package.